Guidelines Downloads
Additional Information on CRC screening recommendations
SUMMARY OF CURRENT GUIDELINE RECOMMENDATIONS AND CHOICE OF TEST
Recommendations | USPSTF 20211 | ACS 20183 | ACG 20212 | MSTF 20214,a |
Choice of Test | Clinicians and patients may consider a variety of factors in deciding which test may be best for each person | High-sensitivity stool- based test or a structural (visual) exam, depending on patient preference and test availability | Colonoscopy and FIT as primary screening
modalities, with flex sig, mt-sDNA, CTC, or colon capsule for those unable or unwilling to undergo colonoscopy or FIT
|
Screening with colonoscopy every 10 years or annual FIT as first-tier options |
Colonoscopy | Every 10 years | Every 10 years | Every 10 years | Every 10 years (Tier 1) |
CT colonography | Every 5 years | Every 5 years | Every 5 years | Every 5 years (Tier 2) |
FS | Every 5 years | Every 5 years | Every 5-10 years | Every 5 or 10 years (Tier 2) |
FS with FIT | FS every 10 years with annual FIT | -- | -- | -- |
Capsule Colonoscopy | -- | -- | Every 5 years |
Every 5 years (Tier 3) |
hs-gFOBT | Annual | Annual | -- | -- |
FIT | Annual | Annual | Annual | Annual (Tier 1) |
mt-sDNAa | Every 1 to 3 years | Every 3 years | Every 3 years |
Every 3 years (Tier 2) |
All Positive Results On Non-colonoscopy Screening Tests Should Be Followed Up with a Timely Colonoscopy1-4 |
All positive results on non-colonoscopy screening tests should be followed up with a timely colonoscopy1-4
- There is a trend for increasing incidence of CRC in adults younger than age 50, and modeling suggests that starting CRC screening at age 45 may moderately increase life-years gained and decrease CRC cases and deaths compared with beginning at age 501, 7-9
- Study data cited in the USPSTF guidelines reflect the accuracy of each method after only a single application rather than a series of repeated screenings1
NATIONAL GUIDELINES RECOMMEND SHARED DECISION MAKING TO IMPROVE SCREENING ADHERENCE
National Guidelines Recommend Shared Decision Making to Improve Screening Adherence | |||||
US Preventive Services Task Force (USPSTF) 20211 |
“Several recommended screening tests are available. Clinicians and patients may consider a variety of factors in deciding which test may be best for each person” “Discussion with patients may help better identify screening tests that are more likely to be completed by a given individual” |
||||
American Cancer Society (ACS) 20183 |
“The importance of offering a choice between structural or stool-based testing is included in this guideline in recognition of the role of patient values and preferences and as a practical implementation strategy to improve adherence” |
||||
American College of Gastroenterology |
“The ‘ideal’ screening test should be noninvasive, have high sensitivity and specificity, be safe, readily available, convenient, and inexpensive. For CRC screening, there are multiple approved tests and strategies, each with its strengths and weaknesses. In some instances, the ‘best’ screening test can be considered the one that is acceptable to the patient and gets completed.” |
- In shared decision making, health care providers offer options and describe their risks and benefits, and patients express their preferences and values6
- Each screening modality has different considerations for implementation that may facilitate patient uptake of and adherence to screening or serve as a barrier1
- Because adherence to continued screening is important, it is recommended to discuss screening considerations with each individual to determine the best screening program for them based on their preferences and availability1
Members of the Guideline Panels for National Organizations
USPSTF10 | ACS11,3 | ACG2,13 | MSTF12-15 |
|
|
|
|
AVERAGE- VS HIGH-RISK
ACG: American College of Gastroenterology, ACS: American Cancer Society, CRC: colorectal cancer, CTC: computed tomography colonography, FIT: fecal immunochemical test, FS: flexible sigmoidoscopy, hs-gFOBT: high sensitivity guaiac-based fecal occult blood test, MSTF: United States Multi-Society Task Force on Colorectal Cancer, mt-sDNA: multi-target stool DNA test, USPSTF: United States Preventive Services Task Force.
References
1 Davidson KW, Barry MJ, Mangione CM, et al. Screening for colorectal cancer: US Preventive Services Task Force recommendation statement. JAMA. 2021;325(19):1965-1977.
2 Shaukat A, Kahi CJ, Burke CA, et al. ACG clinical guidelines: colorectal cancer screening 2021. Am J Gastroenterol. 2021;116:458-479.
3 Wolf AMD, Fontham ETH, Church TR, et al. Colorectal cancer screening for average-risk adults: 2018 guideline update from the American Cancer Society. CA Cancer J Clin. 2018;68(4):250-281.
4 Patel SG, May FP, Anderson JC, et al. Updates on age to start and stop colorectal cancer screening: recommendations from the US Multi-Society Task Force on Colorectal Cancer. Gastroenterol. 2022:162(1):285-299.
5 Gupta S, Lieberman D, Anderson JC, et al. Recommendations for follow-up after colonoscopy and polypectomy: a consensus update by the US Multi-Society Task force on Colorectal Cancer. Gastroenterol. 2020;158(4):1131-1153.e5.
6 Barry MJ, Edgman-Levitan. Shared decision making--pinnacle of patient-centered care. N Engl J Med. 2012;366(9):780-781.
7 Siegel RL, Miller KD, Wagle NS, et al. Colorectal cancer statistics, 2023. CA Cancer J Clin. 2023;73(3):233-254.
8 Knudsen AB et al. Agency for Healthcare Research and Quality; 2021. AHRQ publication 20-05271-EF-2.
9 Knudsen AB, et al. Colorectal cancer screening: an updated modeling study for the US Preventive Services Task Force. JAMA. 2021;325(19):1998-2011.
10 United States Preventive Services Task Force. About the USPSTF. Accessed June 4, 2023. https://www.uspreventiveservicestaskforce.org/Page/Name/about-the-uspstf
11 American Cancer Society. Who We Are. Accessed June 4, 2023. https://www.cancer.org/about-us/who-we-are.html
12 Rex DK, Boland CR, Dominitz JA, et al. Colorectal cancer screening: Recommendations for physicians and patients from the U.S. Multi-Society Task Force on Colorectal Cancer. Am J Gastroenterol. 2017:112(7):1016-1030.
13 American College of Gastroenterology. About ACG. Accessed June 4, 2023. https://gi.org/about/
14 American Gastroenterological Association. About Us. Accessed June 4, 2023. https://www.gastro.org/about-aga/about-us
15American Society for Gastrointestinal Endoscopy. About ASGE. Accessed June 4, 2023. https://www.asge.org/home/about-asge
Footnotes
aNomenclature based on different guidelines: mt-sDNA, sDNA-FIT or FIT-FECAL DNA.
Last Updated: 06/04/2023